Share Price and Basic Stock Data
Last Updated: June 25, 2025, 10:26 am
| PEG Ratio | 0.00 |
|---|
Competitors of Globe Commercials Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 84.1 Cr. | 4.38 | 6.16/3.20 | 55.7 | 2.77 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 12.6 Cr. | 14.3 | 22.4/13.0 | 1,258 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 |
| Modella Woollens Ltd | 5.16 Cr. | 56.7 | 80.5/52.5 | 3.63 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 45.4 Cr. | 22.2 | 25.5/10.2 | 45.8 | 15.2 | 0.00 % | % | % | 10.0 |
| MRP Agro Ltd | 131 Cr. | 118 | 174/99.3 | 18.9 | 29.3 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 10,665.90 Cr | 174.36 | 133.11 | 113.81 | 0.23% | 14.82% | 8.04% | 7.86 |
Quarterly Result
| Metric | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| Sales | 35.26 | 35.98 | 49.86 | 177.81 | 176.55 |
| Expenses | 34.40 | 35.08 | 48.44 | 172.40 | 170.95 |
| Operating Profit | 0.86 | 0.90 | 1.42 | 5.41 | 5.60 |
| OPM % | 2.44% | 2.50% | 2.85% | 3.04% | 3.17% |
| Other Income | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.86 | 0.90 | 1.46 | 5.41 | 5.60 |
| Tax % | 25.58% | 27.78% | 27.40% | 26.06% | 26.07% |
| Net Profit | 0.64 | 0.65 | 1.05 | 4.00 | 4.14 |
| EPS in Rs | 1.07 | 1.08 | 1.75 | 6.66 | 6.90 |
Last Updated: January 5, 2025, 8:02 am
Below is a detailed analysis of the quarterly data for Globe Commercials Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Sales, as of Sep 2024, the value is 176.55 Cr.. The value appears to be declining and may need further review. It has decreased from 177.81 Cr. (Jun 2024) to 176.55 Cr., marking a decrease of 1.26 Cr..
- For Expenses, as of Sep 2024, the value is 170.95 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 172.40 Cr. (Jun 2024) to 170.95 Cr., marking a decrease of 1.45 Cr..
- For Operating Profit, as of Sep 2024, the value is 5.60 Cr.. The value appears strong and on an upward trend. It has increased from 5.41 Cr. (Jun 2024) to 5.60 Cr., marking an increase of 0.19 Cr..
- For OPM %, as of Sep 2024, the value is 3.17%. The value appears strong and on an upward trend. It has increased from 3.04% (Jun 2024) to 3.17%, marking an increase of 0.13%.
- For Other Income, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Interest, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2024, the value is 5.60 Cr.. The value appears strong and on an upward trend. It has increased from 5.41 Cr. (Jun 2024) to 5.60 Cr., marking an increase of 0.19 Cr..
- For Tax %, as of Sep 2024, the value is 26.07%. The value appears to be increasing, which may not be favorable. It has increased from 26.06% (Jun 2024) to 26.07%, marking an increase of 0.01%.
- For Net Profit, as of Sep 2024, the value is 4.14 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2024) to 4.14 Cr., marking an increase of 0.14 Cr..
- For EPS in Rs, as of Sep 2024, the value is 6.90. The value appears strong and on an upward trend. It has increased from 6.66 (Jun 2024) to 6.90, marking an increase of 0.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
| Metric | Mar 2024 |
|---|---|
| Sales | 162 |
| Expenses | 158 |
| Operating Profit | 4 |
| OPM % | 3% |
| Other Income | 0 |
| Interest | 0 |
| Depreciation | 0 |
| Profit before tax | 4 |
| Tax % | 27% |
| Net Profit | 3 |
| EPS in Rs | 5.08 |
| Dividend Payout % | 0% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 61% |
| 3 Years: | 71% |
| 1 Year: | 54% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: Unknown
No data available for the Balance Sheet data table.
Cash Flow
| Month | Month | Mar 2024 | |
|---|---|---|---|
No data available for the Financial Efficiency data table.
No valid data available for the Shareholding
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 5.09 |
| Diluted EPS (Rs.) | 5.09 |
| Cash EPS (Rs.) | 5.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.83 |
| Revenue From Operations / Share (Rs.) | 270.52 |
| PBDIT / Share (Rs.) | 6.97 |
| PBIT / Share (Rs.) | 6.97 |
| PBT / Share (Rs.) | 6.97 |
| Net Profit / Share (Rs.) | 5.09 |
| NP After MI And SOA / Share (Rs.) | 5.09 |
| PBDIT Margin (%) | 2.57 |
| PBIT Margin (%) | 2.57 |
| PBT Margin (%) | 2.57 |
| Net Profit Margin (%) | 1.88 |
| NP After MI And SOA Margin (%) | 1.88 |
| Return on Networth / Equity (%) | 24.43 |
| Return on Capital Employeed (%) | 29.94 |
| Return On Assets (%) | 5.23 |
| Long Term Debt / Equity (X) | 0.11 |
| Total Debt / Equity (X) | 0.11 |
| Current Ratio (X) | 1.14 |
| Quick Ratio (X) | 1.10 |
| Enterprise Value (Cr.) | 17.93 |
| EV / Net Operating Revenue (X) | 0.11 |
| EV / EBITDA (X) | 4.29 |
| MarketCap / Net Operating Revenue (X) | 0.10 |
| Price / BV (X) | 1.32 |
| Price / Net Operating Revenue (X) | 0.10 |
| EarningsYield | 0.18 |
After reviewing the key financial ratios for Globe Commercials Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 20.83. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 20.83. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 270.52. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 24, the value is 24.43. This value is within the healthy range. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 24, the value is 29.94. This value is within the healthy range. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 24, the value is 5.23. This value is within the healthy range. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.11. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 24, the value is 1.14. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 24, the value is 1.10. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 24, the value is 17.93. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 24, the value is 4.29. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.10. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 24, the value is 1.32. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.10. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For EarningsYield, as of Mar 24, the value is 0.18. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Globe Commercials Ltd:
- Net Profit Margin: 1.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.94% (Industry Average ROCE: 14.82%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 24.43% (Industry Average ROE: 8.04%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 6.35 (Industry average Stock P/E: 133.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.88%
About the Company - Qualitative Analysis
Globe Multi Ventures Ltd. is a Public Limited Listed company incorporated on 09/01/1985 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L52110MH1985PLC293393 and registration number is 293393. Currently company belongs to the Industry of Trading. Company's Total Operating Revenue is Rs. 203.45 Cr. and Equity Capital is Rs. 6.00 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | #51, V Mall, Ground Floor, Asha Nagar, Tahkur Complex, Mumbai Maharashtra 400091 | globemultiventures@gmial.com http://www.globecommercials.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mallikarjunan Venkatraman | Ind.& Non Exe.Director |
| Mrs. Sivalenka Kameswari | Whole Time Director |
| Mr. Satya Murthy Sivalenka | Non Exe.Non Ind.Director |
| Mr. Venkat Raman Ayinam | Ind.& Non Exe.Director |